Reduced expression of a novel μ-opioid receptor (MOR) subtype MOR-1B in CXBK mice: Implications of MOR-1B in the expression of MOR-mediated responses

European Journal of Neuroscience

Volumn 18, Issue 12, 2003, Pages 3193-3198

  Narita, Minoru ^a   Imai, Satoshi ^a   Ozaki, Satoru ^a   Suzuki, Masami ^a   Narita, Michiko ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Alternative splice variant; Antinociceptive effect; Genetics; Opioid receptor; Pain controlling system

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; ENDOMORPHIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR 1B; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG SENSITIVITY; EXON; GENE; GENE EXPRESSION; GENE ISOLATION; INBRED STRAIN; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE STRAIN; MU OPIOID RECEPTOR GENE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; TAIL FLICK TEST;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL MEMBRANE; DOWN-REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; PAIN; PROTEIN ISOFORMS; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; SULFUR RADIOISOTOPES;

EID: 0347419241     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2003.03052.x     Document Type: Article

References (29)

1. Abbadie, C., Pan, Y.-X., Drake, C.T. & Pasternak, G.W. (2000) Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. Neuroscience, 100, 141-153.
2. Abbadie, C., Pasternak, G.W. & Aicher, S.A. (2001) Presynaptic localization of the carboxy-terminus epitopes of the μ opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience, 106, 833-842.
3. Brown, H.E., Garcia, M.M. & Harlan, R.E. (1998) A two focal plane method for digital quantification of nuclear immunoreactivity in large brain areas using NIH-image software. Brain Res. Protoc., 2, 264-272.
4. Chen, H.-C., Seybold, V.S. & Loh, H.H. (2000) An autoradiographic study in μ-opioid receptor knockout mice. Mol. Brain Res., 76, 170-172.
5. Goldberg, I.E., Rossi, G.C., Letchworth, S.R., Mathis, J.P., Ryan-Moro, J., Leventhal, L., Su, W., Emmel, D., Bolan, E.A. & Pasternak, G.W. (1998) Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther., 286, 1007-1013.
6. 1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique. Proc. Natl. Acad. Sci. USA, 82, 6667-6671.
7. Haley, M.J. & McCormick, W.G. (1957) Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol., 12, 12-15.
8. Koch, T., Schulz, S., Schroder, H., Wolf, R., Raulf, E. & Hollt, V. (1998) Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalizaiton and receptor resensitization. J. Biol. Chem., 273, 13652-13657.
9. Ling, G.S.F., Spiegel, K., Lockhart, S.H. & Pasternak, G.W. (1986) Naloxonazine actions in vivo. Eur. J. Pharmcol., 129, 33-38.
10. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Menr, M.L., Dolle, P., Tzavara, E., Hanoune, J., Roques, B.P. & Kiffer, B.L. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature, 383, 819-823.
11. 2 and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice. Brain Res., 360, 108-116.
12. 2 opioid binding in the mouse central nervous system. Brain Res., 360, 117-129.
13. 1-opioid receptors in the fentanyl-or morphine-induced antinociception at supraspinal and spinal sites. Life Sci., 70, 2341-2354.
14. 5]enkephalin. J. Neurosci., 21, 3715-3720.
15. Narita, M., Mizoguchi, H., Narita, M., Sora, I., Uhl, G.R. & Tseng, L.F. (1999) Absence of G-protein activation by μ-opioid receptor agonists in the spinal cord of μ-opioid receptor knockout mice. Br. J. Pharmacol., 126, 451-456.
16. Narita, M., Mizoguchi, H., Suzuki, T., Narita, M., Dun, N.J., Imai, S., Yajima, Y., Nagase, H., Suzuki, T. & Tseng, L.F. (2001b) Enhanced μ-opioid responses in the spinal cord of mice lacking protein kinase Cγ isoform. J. Biol. Chem., 18, 15409-15414.
17. Pan, Y.-X., Xu, J., Mahurter, L., Bolan, E., Xu, M. & Pasternak, G.W. (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. USA, 98, 14084-14089.
18. Pasternak, G.W. (2001a) Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci., 22, 67-70.
19. Pasternak, G.W. (2001b) Insights into mu opioid pharmacology: The role of mu opioid receptor subtypes. Life Sci., 68, 2213-2219.
20. Rossi, G.C., Leventhal, L., Pan, Y.-X., Cole, J., Su, W., Bodnar, R.J. & Pasternak, G.W. (1997) Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6β-glucuronide antinociception. J. Pharmacol. Exp. Ther., 281, 109-114.
21. Sanchez-Blazquez, P., DeAntoio, I., Rodriguez-Diaz, M. & Garzon, J. (1999) Antisense oligodeoxynucleotide targeting distinct exons of the cloned mu-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice. Antisense Nucl. Acid Drug Dev., 9, 253-260.
22. Schulz, S., Schreff, M., Koch, T., Zimprich, A., Gramsch, C., Elde, R. & Hollt, V. (1998) Immunolocalization of two μ-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience, 82, 613-622.
23. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R.S., Donovan, D.M., Miner, L.L. & Uhl, G.R. (1997) Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA, 94, 1544-1549.
24. Standifer, K.M. & Pasternak, G.W. (1997) G proteins and opioid receptor-mediated signalling. Cell. Signal., 9, 237-248.
25. Stefano, G.B., Goumon, Y., Casares, F., Cadet, P., Fricchione, G.L., Rialas, C., Peter, D., Sonetti, D., Guarna, M., Welters, I.D. & Bianchi, E. (2000) Endogenous morphine. Trends Neurosci., 23, 436-442.
26. Wolf, R., Koch, T., Schulz, S., Klutzny, M., Schroder, H., Raulf, E., Buhling, F. & Hollt, V. (1999) Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat μ opioid receptor. Mol. Pharmacol., 55, 263-268.
27. Wolozin, B.L. & Pasternak, G.W. (1981) A classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA, 78, 6181-6185.
28. Zimprich, A., Simon, T. & Hollt, V. (1995a) Cloning and expression of and isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett., 359, 142-146.
29. 2+ mobilization. Neuroreport, 7, 54-56.